Ph.D., President and Chief Executive Officer of Aileron. "Additionally, we saw dose dependent effects in five biomarkers ...

On Wednesday, Aileron Therapeutics Inc (NASDAQ; ALRN) revealed topline data from Cohort 2 of its Phase 1b trial of safety and ...

Waltham, Massachusetts Friday, November 15, 2024, 15:00 Hrs [IST] ...

Aileron Therapeutics (ALRN) announced positive topline data from Cohort 2 of its Phase 1b clinical trial evaluating the safety and tolerability ...

(RTTNews) - Aileron Therapeutics, Inc. (ALRN), Wednesday announced positive topline data from the cohort 2 of Phase 1b study evaluating LTI-03 in patients with idiopathic pulmonary fibrosis (IPF).

Announced promising safety and positive biomarker data from Cohort 2 (5mg BID) of the Phase 1b clinical trial of LTI-03 in idiopathic pulmonary fibrosis (IPF) patients demonstrating dose dependent ...

And yet, for the first time this year, I'm about to recommend it to you, and that's because Best Buy has started the Black ...

Dassault's fly-by-wire system, or digital flight control system as they named it, first became evident in the Mirage 2000 ...

Flow motion, or the muscle memory behind setting up an aircraft, is an integral part of a pilot’s daily routine that can be ...

Jet.AI Inc. (NASDAQ: JTAI) shares are trading higher Wednesday after the company's board approved a $2 million share ...